ArticleJMIR mHealth and uHealth2025
Evolving Digital Health Technologies: Aligning With and Enhancing the National Institute for Health and Care Excellence Evidence Standards Framework.
Article in JMIR mHealth and uHealth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Association of an AI-Enabled Gamified Mobile Health App on Blood Pressure Outcomes in a Matched Cohort.Journal of general internal medicine · 2026Article
- Digital health for cancer prevention: implications for current and future traditional in-person programs.Cancer causes & control : CCC · 2026Article
- Machine Learning-Integrated Metabolomics for Precision Pharmacotherapy: Advances, Challenges, and Clinical Translation.Metabolites · 2026Review
- Portraying Ethical Risks of Medical AI: Mixed Methods Study From Connotation Definition to a Survey on Physicians' Cognition.Journal of medical Internet research · 2026Article
- Clinical artificial intelligence (AI) in Japan: Regulatory pathways, domain-specific evidence, and its data infrastructure from an international perspective.Global health & medicine · 2026Review
- Digital Health Solutions for Type 2 Diabetes and Prediabetes: Systematic Review of Engagement Barriers, Facilitators, and Outcomes.JMIR diabetes · 2026Review
- Narrative-driven virtual reality serious game to support type 1 diabetes self-management in children.Scientific reports · 2025Article
- Artificial Intelligence and the future of clinical trials.Contemporary clinical trials communications · 2025Article
- Beyond techno-optimism: four critical limitations in the UK's AI policy for health care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2025Article
- Evolving Digital Health Technologies: Aligning With and Enhancing the National Institute for Health and Care Excellence Evidence Standards Framework.JMIR mHealth and uHealth · 2025Article
- Bridging the digital divide: student-led literacy initiatives in diabetes management.Frontiers in clinical diabetes and healthcare · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Unlabelled: The rapid advancement of artificial intelligence (AI)-driven diagnostics and wearable health technologies is transforming health care delivery by enabling real-time health monitoring and early disease detection. These innovations are catalyzing a shift toward personalized medicine, with interventions tailored to individual patient profiles with unprecedented precision. This paper examines the current National Institute for Health and Care Excellence (NICE) evidence standards framework (ESF) for digital health technologies (DHTs) and evaluates the challenges associated with integrating DHTs into existing health and care systems. A comprehensive review of the NICE ESF guidelines was conducted, alongside an evaluation of their applicability to emerging AI and wearable technologies. Key limitations and barriers were identified, with particular focus on the framework's responsiveness to technologies that evolve through machine learning and real-world data integration. Our findings indicate that while the NICE ESF provides a structured approach for evaluating DHTs, it lacks the adaptability required for rapidly evolving innovations. The framework does not sufficiently incorporate real-world evidence or support continuous learning models, which are critical for the safe and effective deployment of AI-based diagnostics and wearables. To remain effective and relevant, the NICE ESF should transition to a dynamic, adaptive model co-designed with industry stakeholders. By embedding real-world evidence-based strategies and promoting transparency, efficiency, and collaborative innovation, the updated framework would better facilitate the integration of AI-driven diagnostics and wearables into health care systems, ultimately enhancing patient outcomes and optimizing health care delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.